Stocks Health care VYCO
OTC · Health careVycor Medical Inc (VYCO)
Vycor Medical Inc brought in $1.8M of revenue over the twelve months to June 30, 2026, up 1.6% from a year earlier. It posted a net loss of $59.9K. In fiscal 2025 capital spending exceeded operating cash flow by $18.7K. At June 30, 2026 it held $158.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.
Watch VYCO in 60 secondsWhat Vycor Medical Inc does
Vycor Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker VYCO.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.9M | -$72.4K | -$0.01 | -$18.7K |
| 2024 | $1.6M | -$107.2K | -$0.01 | $54.7K |
| 2023 | $1.5M | -$69.7K | -$0.01 | $20K |
| 2022 | $1.2M | -$404.9K | -$0.02 | -$219.8K |
| 2021 | $1.4M | -$435.7K | -$0.03 | -$17K |
| 2020 | $1.1M | -$822.5K | -$0.04 | -$310.8K |
Full financial statements: income, balance sheet and cash flow
Where VYCO ranks in Health care
Latest SEC filings
What Vycor Medical Inc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 14, 2026
- August 14, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 16% to $418.3K versus the same quarter last year; diluted EPS $0.00 versus $0.00.
- May 15, 2026
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue rose 5.1% to $458.5K versus the same quarter last year; diluted EPS $0.00 versus -$0.01.
- March 31, 2026
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue rose 17% to $1.9M versus the prior year; diluted EPS -$0.01 versus -$0.01.
- November 14, 2025
- November 14, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 31% to $513.8K versus the same quarter last year; diluted EPS $0.00 versus -$0.01.
- August 8, 2025
- August 8, 2025
Questions about VYCO
What does Vycor Medical Inc do?
Vycor Medical Inc is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on OTC under the ticker VYCO.
Is Vycor Medical Inc profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $59.9K on revenue of $1.8M.
How much revenue does Vycor Medical Inc make?
Over the twelve months to June 30, 2026 Vycor Medical Inc reported revenue of $1.8M. That is 1.6% more than a year earlier.
When did Vycor Medical Inc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.
Similar companies
Compare VYCO with
Follow VYCO
Get an email when Vycor Medical Inc files with the SEC: results, executive changes, material agreements and annual reports.
Follow VYCO: get an email when it filesWhere the numbers come from
Financial figures are the values Vycor Medical Inc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.